Delivery Order SPE2DB22D1017-SPE2DB25FYQPR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Januvia 100 mg tablets (90-count) valued at $4,732.64, with an ultimate completion date of September 11, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a single pharmaceutical procurement under a larger contract vehicle. The ordering activity and AmerisourceBergen's corporate office, located in Conshohocken, Pennsylvania, serve as the contracting entities and place of...
- The Defense Logistics Agency awarded a delivery order valued at $1,779.46 to AmerisourceBergen Drug Corp for Januvia 100 mg tablets (90-count supply) on August 8, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price, non-set-aside contract for delivery to the vendor's corporate headquarters location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal pharmaceutical supply relationship with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Januvia 100 mg tablets (90-count units) at a ceiling value of $1,091.46. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a competitively awarded contract with no set-aside designation. The product will be sourced from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Januvia 100 mg tablets (90-count) with a ceiling value of $2,105.91. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this award. No set-aside designation was used in this competitive...
- The Defense Logistics Agency awarded a $3,274.38 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Januvia 100 mg tablets (90-count units). This firm fixed price delivery order, with an ultimate completion date of August 14, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $7,401.38 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Januvia 100 mg tablets (90-count packages) valued at $1,718.04. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 10, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single line item purchase under AmerisourceBergen's existing pharmaceutical supply relationship...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Januvia 100 mg tablets in quantities of 90 units, with a ceiling value of $1,269.42. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and is scheduled for completion by September 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Januvia 50 mg tablets (90-count package) valued at $1,109.94 under a firm fixed-price contract. This delivery order, issued on August 22, 2025, represents a non-competitive, non-set-aside award with an ultimate completion date of August 25, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Januvia 100 mg tablets (90-count) under a firm fixed-price contract valued at $1,122.20. The award, which is effective through August 19, 2025, was issued as a non-set-aside competitive award and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's corporate office location in...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYQPRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Januvia 100 mg tablets (90-count units) with a contract value of $7,676.40 and a firm fixed price structure. The award, made on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications, vaccines, and specialized medical commodities across multiple therapeutic domains. The delivery order supports the Defense Health Agency and other federal healthcare systems requiring diabetes management medications as part of their medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 9/12/25 |